Harvard Bioscience Inc
Research Harvard Bioscience Inc (HBIO) on Bullrun: market cap USD 37.51M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHBIO
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Market capUSD 37.51M
- Financial periodQ2 2026
- RevenueUSD 22.73M
- Net income-USD 2.91M
- Free cash flow-USD 591.00K
- Gross margin55.6%
Valuation Snapshot
latest market cap is USD 37.51M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 86.55M | -USD 56.70M | USD 5.47M | 57.7% | -1.28 | USD 8.61M | USD 35.87M | USD 13.73M |
| FY2024 | USD 94.14M | -USD 12.41M | -USD 1.20M | 58.2% | -0.28 | USD 4.11M | USD 36.96M | USD 63.34M |
| FY2023 | USD 112.25M | -USD 3.42M | USD 12.24M | 58.9% | -0.08 | USD 4.28M | USD 36.84M | USD 73.07M |
| FY2022 | USD 113.34M | -USD 9.52M | -USD 438.00K | 53.7% | -0.23 | USD 4.51M | USD 47.10M | USD 72.22M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-12 | USD 37.51M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 29.96M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 93.00M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 228.38M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 115.39M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 290.06M | n/a | n/a | n/a |
About Harvard Bioscience Inc
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Harvard Bioscience Inc's market cap?
Harvard Bioscience Inc's market capitalization is USD 37.51M.
What does Harvard Bioscience Inc do?
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally.